- £463.09m
- £436.04m
- £43.75m
Annual income statement for Cerillion, fiscal year end - September 30th, GBP millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 20.8 | 26.1 | 32.7 | 39.2 | 43.8 |
| Cost of Revenue | |||||
| Gross Profit | 15.3 | 20.4 | 25.5 | 30.8 | 35.2 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 18 | 18.5 | 22 | 23.9 | 25.3 |
| Operating Profit | 2.8 | 7.52 | 10.7 | 15.3 | 18.4 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 2.64 | 7.43 | 10.9 | 16.1 | 19.7 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 2.61 | 6.43 | 9.34 | 12.9 | 15.3 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 2.61 | 6.43 | 9.34 | 12.9 | 15.3 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 2.61 | 6.43 | 9.34 | 12.9 | 15.3 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.088 | 0.217 | 0.367 | 0.443 | 0.524 |
| Dividends per Share |